NCT02279745: A reported trial by United Therapeutics
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02279745 |
|---|---|
| Title | An Open-label Extension Study of Ralinepag in Patients With Pulmonary Arterial Hypertension |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 8, 2015 |
| Completion date | March 29, 2021 |
| Required reporting date | March 29, 2022, midnight |
| Actual reporting date | Oct. 20, 2021 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |